Connect Biopharma Holdings Limited (CNTB) Social Stream
CONNECT BIOPHARMA HOLDINGS LTD (CNTB) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering CONNECT BIOPHARMA HOLDINGS LTD.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-18 | 3 | $32 | $27 | $30 | $1.18 | 2442.37% |
| 2022-04-08 | 3 | $25 | $19 | $22 | $1.18 | 1764.41% |
| 2022-05-04 | 3 | $13 | $1.5 | $7.833 | $1.18 | 563.81% |
| 2022-06-06 | 4 | $13 | $1.5 | $7.125 | $1.18 | 503.81% |
| 2022-09-15 | 4 | $9 | $1.75 | $5.687 | $1.18 | 381.95% |
| 2023-02-08 | 2 | $7 | $1.75 | $5.187 | $1.18 | 339.58% |
| 2023-04-12 | 3 | $7 | $1.75 | $5.187 | $1.18 | 339.58% |
| 2023-07-11 | 2 | $7 | $5 | $6.333 | $1.18 | 436.69% |
| 2023-09-13 | 2 | $7 | $5 | $6 | $1.18 | 408.47% |
| 2023-12-12 | 1 | $7 | $7 | $7 | $1.18 | 493.22% |
The Trend in the Analyst Price Target
CNTB's average price target has moved up $0.67 over the prior 154 days.
Over the past 44 weeks, CNTB's average upside potential has been 507.86%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-08 | 4 | 7 | 1.75 | 5.187 | 1.17 | 343.33% |
| 2023-02-08 | 2 | 7 | 1.75 | 5.187 | 1.17 | 343.33% |
| 2023-04-12 | 3 | 7 | 1.75 | 5.187 | 1.12 | 363.12% |
| 2023-04-12 | 2 | 7 | 1.75 | 5.187 | 1.12 | 363.12% |
| 2023-04-12 | 2 | 7 | 5.00 | 6.333 | 1.12 | 465.45% |
CNTB Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
CNTB's average broker recommendation rating improved by 0 over the prior 25 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CNTB as an investment opportunity.
- CNTB has a higher upside potential (average analyst target price relative to current price) than 1034.11% of all US stocks.
- CONNECT BIOPHARMA HOLDINGS LTD's number of analysts covering the stock is higher than 78.09% of all US stocks.
- CONNECT BIOPHARMA HOLDINGS LTD's average analyst price target is greater than 114.17% of all US stocks.
- To contextualize these metrics, consider that out of Healthcare stocks, CONNECT BIOPHARMA HOLDINGS LTD's variance in analysts' estimates is lower than -479.96% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CONNECT BIOPHARMA HOLDINGS LTD are EWTX, RAIN, and VERA.
View All Top Stocks by Price Target
What is the outlook for CNTB? Use POWR Ratings for clearer insight into price direction.